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ABSTRACT

The mercury coordination chemistry of the cyclic dipeptides cyclo(L-alanyl-Lhistidyl) (cAH), cyclo(L-histidyl-L-histidyl) (cHH), cyclo(L-alanyl-L-methionyl) (cAM),
and cylco(L-methionyl-L-methionyl) (cMM) was investigated by proton NMR.
Comparisons were made between the studies of cyclo(L-histidyl-L-histidyl) and cyclo(Lalanyl-L-histidyl), as well as between the cyclo(L-methionyl-L-methionyl) and cyclo(Lalanyl-L-methionyl) studies. Trends in chemical shift as a function of the metal-todipeptide ratio were examined, and analysis of the Hg(II):cAM and Hg(II):cMM titration
studies suggest the possibility o f sulfur-mercury(II) interaction. The 8 nitrogen of the
histidyl side chain was tentatively established as the primary coordination site for Hg(II)
from analysis o f the titration studies o f Hg(II):cAH and Hg(II):cHH. Cadmium(II):cHH
titration studies suggest the possible formation of a 1:2 Cd(II):cHH complex. Also,
cyclo(L-leucyl-D-prolyl) was synthesized for future solid state NMR evaluation of
molecular motion in the pure form and as an inclusion complex o f a cyclodextrin.
Cyclo(L-leucyl-D-prolyl) was also fragmented using mass spectrometry and linear
intermediates o f this dipeptide were prepared for future analysis by mass spectrometry.

Characterization of Cyclic and Linear Dipeptides

INTRODUCTION
Imagining a cellular world without proteins is a very difficult, if not impossible,
task.

Enzyme catalysis dictates physiological conditions in every cell.

Furthermore,

proteins give cells structural support and regulate gene expression. Proteins transport
energy during photosynthesis and provide defense against foreign invasion. Even more
remarkable is that proteins can perform all these functions with different numbers and
sequences o f only 20 amino acids.
Over 30 years ago, Anfmsen and his colleagues proposed that the linear sequence
o f amino acids determines the final three-dimensional folded structure o f a protein.1 The
three-dimensional shape of the native protein is what is required for proteins to achieve
complete biological activity. Errors within the native protein structure or problems with
the protein folding mechanisms within the cellular environment are the basis for
numerous human diseases. There are several types of interactions that help to properly
stabilize the native structure of a protein so that proper folding occurs. These stabilizing
elements include interactions between amino acids within the same protein chain and
amino acids on different protein chains, as well as hydrophobic and hydrophilic
interactions with the surrounding environment. Protein structure can also be stabilized by
interactions between amino acid cofactors, like metal ions. While there have been many
recent developments and advances in the characterization of proteins by mass
spectrometry, X-ray diffraction, and multinuclear NMR techniques, our understanding of
the folding process is still very limited.
2

3

Tandem mass spectrometry is a technique that can be used to determine a
protein’s fragmentation pattern, thereby predicting the strength of bonds within the
compound.

X-ray crystallography is a technique used to obtain detailed structural

information about the metal binding sites of native proteins. Large, well-ordered crystals
o f the protein are vital to determination of protein structure by this technique. Solutionstate NMR, on the other hand, does not require well-formed crystals, and enables the
characterization o f metal-ligand interactions in solution, through the study of nuclear
shielding interactions between the electron clouds of the ligand and metal. Solid-state
NMR provides an opportunity to monitor characteristics of disordered solids, and relate
them to physical properties and molecular motion.

Mass Spectrometry
Mass spectrometry is an analytical technique in which analytes are converted to
gas-phase ions, which are subsequently separated by their mass-to-charge ratio.

The

resulting display o f ion abundance vs. mass-to-charge ratio is the mass spectrum o f the
analyte.3 Early mass spectrometers were based on the deflection o f ions moving in a
magnetic field.4 The sample was introduced, as a vapor, into a vacuum chamber where
positive ions were formed by electron bombardment. Negatively charged plates at one
end of the chamber then accelerated the parent ions and product ions resulting from
subsequent fragmentation through the magnetic field 4 The degree of deflection in the
magnetic field was based on the ion’s mass, velocity, and charge, and the amount of
deflection was inversely proportional to each fragment’s mass. Ions of interest were

detected in an ion collector, where an electronic signal was generated and amplified prior
to recording the results as a function of mass-to-charge ratio.4
This technique proved unsuitable for protein analysis primarily because proteins
are non-volatile compounds and denature when heated.

The recently developed

techniques of electrospray ionization (ESI) and matrix-assisted laser desorption
ionization (MALDI), however, have permitted researchers to analyze proteins and other
large biomolecules.5 In an ESI experiment, the pH of a solution is varied to form ions in
solution, which are transferred to the gas phase via electric potential.5 In contrast,
MALDI experiments use lasers to ionize some organic matrix, in which the analytes of
interest are dissolved.5 These two ion sources have allowed both single stage and tandem
mass spectrometry experiments to be performed on biomolecules.
Tandem mass spectrometry (MS/MS) is a technique that was developed to
analyze complex mixtures.

MS/MS also provides researchers with the opportunity to

elucidate the structures o f large molecules, which is virtually impossible with single-stage
mass spectrometry.

MS/MS experiments can be performed with the two stages of mass

spectrometry (MS-I and MS-II) separated either in space or in time. Separating the two
stages o f mass spectrometry in space involves the use o f multiple mass analyzers, such as
multiple quadrupoles or tandem sectors, which are physically separated.

A soft

ionization source, such as chemical ionization or ESI, is used to produce analyte
molecular ions with little or no fragment ions. MS-I allows only ions of a particular
mass-to-charge ratio to pass through its exit slit. The ions then enter a collision chamber,
usually an rf-only quadrupole, where ions collide with an inert gas, such as argon or
xenon, to induce further dissociation of the ion.3 This type o f fragmentation is called

5

collision-induced dissociation (CED). The resulting product ions are then directed into
MS-II.

Since CID produces many characteristic product ions, the identity of the parent

ion can usually be determined when these product ions are analyzed in the second mass
spectrometer.
The second MS/MS method involves trapping ions in one place so that multiple
stages o f mass spectrometry can be preformed sequentially in time. Ions accumulate in
the ion trap and ions with a single mass-to-charge ratio (m/z) of interest are selected. All
other m/z are removed from the ion trap. The mass-selected ion is then fragmented and
the product ions are analyzed in a second stage o f mass spectrometry in the same
environment.

Both tandem mass spectrometry techniques hold great promise in the

future characterization o f proteins, as they will provide confirmation of peptide sequence,
as well as providing insight into bond strengths and weaknesses within proteins.

X-ray Crystallography
X-ray crystallography is a useful technique that can determine the detailed
structure o f a protein using a single, well-ordered crystal. Unfortunately, crystallization
is impeded by the irregular surfaces o f proteins. Furthermore, mechanism o f metal ion
incorporation into a protein cannot be determined by X-ray analysis.

Nuclear magnetic

resonance (NMR), however, allows for proteins to be studied in solution and as solids,
providing a valuable complement to information obtained through X-ray crystallography
and mass spectrometry.

6

N uclear M agnetic Resonance
NMR is a useful technique for structural characterization because it is potentially
applicable to all nuclei possessing nuclear spin. Isotopes with suitable spin qualities have
an odd atomic weight or an odd number of protons and neutrons. A magnetic field is
created by the spinning motion of charged nuclei. Nuclei with spin 1= Vi are favored in
NMR experiments as there is a marked reduction in the quality o f NMR information
available for nuclei with spin I > Vi. Two possible spin states arise when the magnetic
field o f a spin Vz nucleus interacts with a magnetic field of greater magnitude.

The

nuclear spin vector may be either aligned with the large magnetic field or against it.
Alignment with the external magnetic field is more energetically favorable for the
nucleus and a slight excess o f nuclei populate the lower energy spin state in accordance
with the Boltzman distribution constant.6
NMR

spectroscopy

involves

excitation

between

available

spin

states.

Radioffequency radiation can be used to excite the nuclear spin vector into a higher
energy level(s), producing a non-equilibrated distribution of spin states. Free induction
decay (FID), the result of vector relaxation back to equilibrium, produces a series of
exponentially decaying sine waves, whose amplitudes are plotted as a function of
frequency. A typical NMR is the result of a Fourier transformation of this data, and is
particularly useful as not all nuclei o f the same type resonate at the same frequency and
field. A precession frequency of
co= y ( l- a ) B o

results from the phenomenon called shielding, where y is equal to the magnetogyric ratio,
a constant that describes how much magnetism arises from the spin and a equals the

7

shielding paramater. This effect is called chemical shift and varies depending on the
degree o f shielding o f a particular nucleus and the specific bonds involved.7
Spin coupling is an important aspect of NMR that provides information about the
environment o f a given nucleus.8 Coupling manifests itself in an NMR spectrum as a
split peak. Coupling occurs when through-bond connectivity between two nuclei exists.7
Splitting arises because nuclear spins can be coupled via bonded electrons. The result is
that the nuclei experience two different microenvironments and thereby each resonates at
two slightly different frequencies. This frequency difference is equal to the scalar spin
coupling constant J. The number of types of bonds through which the nuclei are coupled
determines the magnitude o f J. Further, the Karplus relationship
Jxy= A cos 2<() + B cos (j) + C
where A, B, and C are empirical constants and (|) is the dihedral angle, can be used in
conjunction with coupling constants to determine dihedral bond angles.7 However, the
relationship is a causal one, as two different angles can produce the same coupling
constant.7
High-resolution NMR spectra of quadrupolar nuclei can be obtained from solidstate samples. MQ-MAS (multiple quantum magic-angle spinning) is a solid-state NMR
technique that can be employed using conventional NMR spectrometers and probes. In
general, solid-state NMR produces much broader, overlapping spectral lines than
solution-state NMR. The low sensitivity o f solid-state NMR also imposes the need to
signal average multiple spectra to improve the poor signal-to-noise ratios.9 The lower
signal-to-noise ratio o f solid-state NMR compared to solution-state NMR can be
attributed to the different NMR spectrum of each molecular orientation in a solid

compound, whereas with solution-state NMR these differences are averaged out by
molecular tumbling.

However, MAS can be utilized to overcome the drawbacks of

spectral broadening and low signal-to-noise ratios as it narrows spectral lines by
emulating the molecular tumbling observed with solution-state NMR. Employing MAS
involves spinning samples in a rotor with an axis of 54.74° with respect to the magnetic
field. A cubically symmetrical motion, which is imposed by the trajectory, is an adequate
approximation to spherically symmetric motion that spectral broadening is averaged
away and relatively sharp NMR resonances are obtained.9

Metal Ion Coordination to Proteins
The ideal heteronuclear NMR probe possesses spin I = Vi nuclei, which have
narrow resonance ranges, thereby permitting the detection o f heteronuclear coupling.
Abundant nuclei associated with a wide chemical shift range and large coupling constants
1

1

are most useful in NMR studies. Biologically relevant spin I = Vi nuclei include H,

1

C,

15N, and 113Cd. The natural abundance of these nuclei ranges from 1.1% (13C) to 99.9%
(!H). The chemical shift ranges o f these nuclei also vary. Proton NMR is frequently used
to characterize proteins, unfortunately the limited chemical shift range o f this nucleus
11

leads to considerable spectral overlap.

I ^

C and

N are also somewhat unfavorable, as

they are both o f low natural abundance. Fortunately, many proteins incorporate metal
ions into their active sights and NMR characterization of these metal-binding sites may
provide valuable information. Unfortunately, none of the physiologically relevant metals
(e.g. copper, zinc, iron and magnesium) have isotopes with favorable NMR properties. In

9

some cases, however, it is possible to substitute metals possessing favorable NMR
properties for native metal ions and obtain relevant spectroscopic information.
199Hg(II) is one metal ion that possesses favorable NMR characteristics. This ion
has a chemical shift range o f more than 3000 parts per million.10 199Hg is the only spin I
= lA isotope o f mercury.

It has a natural abundance of 16.8% and large coupling

constants.10 In addition, it has a receptivity 5.4 times greater than 13C and its chemical
shift is very sensitive to the number and identity of bound nuclei.11 Mercury NMR may
thus prove to be a valuable technique for elucidating aspects of metalloprotein structure
and folding.
Mercury is known to form complexes with nitrogen, sulfur and phosphorous with
stability rarely exceeded by any other divalent cation.

When compared to several

physiologically essential transition elements, mercury exhibits similar charge and
coordination geometry preferences.

Metal binding studies have shown competition
1 j

between mercury, zinc and copper for protein binding.

In several instances,

metalloenzymes with mercury in place of the normal metal have retained catalytic
activity.10 Several mercury-substituted proteins have been characterized by recently
developed multinuclear NMR techniques demonstrating preservation of protein
structure.

1'K

*

However, an understanding of how and why proteins fold still eludes

researchers.
Greater knowledge o f protein folding processes will ultimately contribute to a
better understanding o f biological systems, as proteins are important in all of the
metabolic pathways o f living organisms. Studies of metal binding to peptides will also
assist in the understanding o f metal binding by proteins, which is important because

10

metal ion transport in body fluids and through membranes is strongly dependent on the
relative complexing ability of amino acids and their peptides. A better understanding of
the mechanism of protein folding itself may provide effective therapies for diseases
caused by altered protein folding, such as Alzheimer’s and scrapie.2
Three-dimensional folding of a polypeptide is, however, a very complex process.
Proteins are synthesized by sequential addition of amino acids onto a linear chain. Since
the folded structure brings amino acids far apart on the chain close together, the exposed
end of the growing protein chain must remain at least partially unfolded until amino acid
assembly is completed. Furthermore, proteins must fold in a heterogeneous aqueous
solution, which provides numerous opportunities for folding/misassociation errors. Cells
have evolved mechanisms, like molecular chaperones, which are responsible for
preventing misassociations and facilitating proper folding under optimal cell conditions.
In addition, some proteins require association with ions or small molecules to perform
their catalytic function.

There is some evidence that these cofactors may sometimes

participate in the folding process.12

A— B
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A----- B
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1

Figure 1: Simplistic model of protein folding.

Most protein folding studies have focused on the unimolecular process for
proteins containing a single amino acid chain and no cofactors. Much simpler model
studies are necessary to develop new tools for investigation of the more complex

11

bimolecular process involved in folding a metalloprotein. Through the detection of
heteronuclear 'H-metal coupling, previous protein metal binding site model studies have
demonstrated Hg(II) binding in solution with both tridentate and tetradentate ligands, but
not lower coordinate ligands.

Both tetradentate and tridentate ligands have limited

degrees of freedom and provide a claw-like feature in binding, thus the development of
an even simpler protein model with similar features would be ideal for future protein
folding studies.
Cyclic dipeptides possess a diketopiperazine ring system which restricts the
degrees of freedom of metal coordinating amino acid side chains.

When the

diketopiperzine ring is in the “boat conformation”, the amino acid side chains are
oriented for pincher-like metal coordination. Cyclic dipeptides can thus be used to mimic

Figure 2: The metal induced cyclic dipeptide "folding" process. R is a metal binding group.

the close proximity of two amino acid side chains bound to a metal ion in a protein active
site. Furthermore, cyclic dipeptides provide an alternative to studying entire proteins by
reducing the high variability associated with linear peptide chains and by achieving

12

greater structural simplicity for characterization by X-ray diffraction, solution-state NMR
studies, solid-state NMR studies, mass spectrometry*, and circular dichroism.
Many functional groups in proteins and peptides are potential metal coordination
sites, as demonstrated in studies of metal binding with simple amino acids and other
compounds. Histidine, for example, is a substantial contributors to protein structure and
function and an essential amino acids in infants.14

Histidine residues bind heme

prosthetic groups in hemeglobin.14 Methionine is another biologically important residue
often encountered in the metal binding sites of proteins.

Methionine is also an

appropriate component for metal-bound ligands in mercury coordination studies because
mercury forms a stable Hg-S bond to sulfur containing amino acid residues, resulting in
“tight binding” to proteins in living systems.15 Investigating methionine and histidine
interactions with mercury (II) will thus provide valuable insight that will aid in further
understanding protein-metal interactions.

Past Studies
Metal Ion/Amino Acid Interactions
To date, there are few detailed studies of metal ion interactions, excluding
terminal functional group effects, with side chain substituents and an amide linkage. In
one existing study, four criteria were used to create model ligands for characterizing
Cu(II) interactions with protein side chains and amide linkages.16 First, terminal carboxyl
or amine groups were excluded from model ligands, except specifically as a side chain

* Uncoordinated cyclic dipeptides will be characterized with mass spectrometry, whereas both
uncoordinated and metal-coordinated cyclic dipeptides will be studied by X-ray diffraction, solution-state
NMR, solid-state NMR, and circular dichroism.

13

function.

Second, model ligands were required to possess an amide linkage a to the

substituted carbon o f any amino acid residue. Third, the model ligands had to be easily
prepared from a variety of natural and synthetic amino acids. Finally, the model ligands
were kept sterically simple, but amenable to synthetic modification. These guidelines are
applicable to cyclic dipeptides proposed for 199Hg NMR studies.16

199H g NMR Studies o f Mercury (II) Substituted Metalloproteins
The mercury ion has chemical characteristics suitable for 199Hg and ]H NMR
investigation of the structure and function of biopolymers.

Mercury (II) preserves

catalytic activity when substituted for native metal ions o f several metalloenzymes.15
Mercury also adopts the coordination environments o f native metals as determined by a
combination o f 199Hg NMR techniques, when substituted into a variety o f Fe, Cu and Zn
metalloproteins.17

199Hg NMR provided insight into allostery of MerR-DNA

interactions.17 The MerR protein activates transcription of genes responsible for mercury
detoxification after changes in intracellular metal ion concentration are detected. The
conformation o f MerR, and its biological activity as a transcription activator, are Hg(II)
dependent.
Previous NMR and circular dichroism (CD) studies characterizing tetrapeptides
have also been used to establish the biological significance o f chelated proteins.
Tetrapeptide fragments Cys-X-Y-Cys (X,Y = amino acid residues) are found in the metal
binding sites o f many metal thiolato proteins.18 These proteins include C. pasteurianum
rubredoxin, Spirulina plaensis ferredoxin, E. coli aspartate carbamoyl transferase, and
renal metallothionem.

Spectroscopic characterizations of Fe 4 S4

complexes of cys-

containing tetrapeptides were determined using !H NMR and CD in a study of

14
*

electrochemical properties of the chelating tetrapeptide complexes.

1

8

*

1

In this study, H

NMR was used to establish the chelation of Cys-X-Y-Cys to the [4Fe-4S] cluster by the
observation of two sets o f characteristic

NMR signals o f CysCpF^.18 Two peaks

around 12-14 ppm (in Me 2 SO-d 6 or dichloromethane-d 2 ) were observed in [4Fe-4S]
complexes o f tripeptides and dipeptides containing a cysteine residue. These peaks were
the result o f non-equivalent CpH2 protons that were contact-shifted by the Fe 4 S4 2+ core
through the C-S-Fe bond . 1 8
The solvent dependence o f lH NMR and CD spectra of [Fe4 S4 (Z-Cys-Gly-AlaCysOMe)2 ] ' were interpreted as demonstrating flexible chelation of the peptide. Circular
dichroism results supported chelating coordination of two cysteine-containing peptides to
•

a single cluster.

18

•

*

This experiment established that the invariant sequence around Fe 4 S4

in bacterial ferredoxins might play an important role in electron transfer, especially in
influencing the direction o f flow o f electrons in biological electron-transfer chains.18

Cyclic Dipeptide or Protein Folding Secondary to Metal Ion Binding
Cyclic diglycine, the simplest cyclic dipeptide, exists in a planar ring
conformation. Replacement o f one or both o f the glycines by an amino acid with a larger
group changes the preferred conformation. When an aryl substituent was used in studies
of 2,5-dioxopiperazine’s (DOP’s), three conformations of the DOP ring were observed:
planar (Figure 3), flagpole boat (Figure 4), and bowspirit boat (Figure 5). 19 Initially
reported as responsible for the ring-shielding effects observed in NMR spectra, the
flagpole conformation appears to be the most common for cyclic dipeptides with two
aromatic sidechains, possibly as a result of attractive forces between the two rings. This

15
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conformation o f DOP ring
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Figure 4: Flagpole boat
conformation o f DOP ring

Figure 5: Bowspirit boat
conformation o f DOP ring

conformation is apparently less favored for non-aromatic substituents.19

In limited

previous studies o f metal binding by cyclic dipeptides, metal binding induced the
flagpole conformation.19
The “folding” process to be investigated involves the cyclic dipeptide ring flip
from the bowspirit structure, with the side chains pointing out, to the flagpole structure
with the side chains both directed at a metal. Cyclic dipeptides with two metal binding
groups, for example cyclo(L-histidyl-L-histidyl) and cyclo(L-methionyl-L-methionyl),
will be compared to those with just one metal binding group. The side chains of the
amino acids histidine (Figure 6) and methionine (Figure 7) are frequently bound to metals
in proteins, while the side chain of alanine (Figure 8) is incapable of metal binding.
Cyclo(L-histidyl-L-histidyl) (Figure 9) and cyclo(L-methionyl-L-methionyl) (Figure 10)

HC
H2

II

-c— c

\ CH

//

N
H+

Figure 6: Histidine side chain

-CH2CH2SCH 3

Figure 7: Methionine side chain

■CHr

Figure 8: Alanine side chain

o
o
Figure 9: Cyclo(L-methionyl-L-methionyl)

Figure 10: Cyclo(L-histidyl-L-histidyl)

are available in one step synthesis from commercially protected amino acids. Protected
dipeptides containing two different amino acids were synthesized as precursors to
cyclo(L-alanyl-L-methionyl) (Figure 11) and cyclo(L-alanyl-L-histidyl) (Figure 12).

NH

NH

NH

HN

HN

O

O
Figure 11: Cyclo(L-alanyl-L-methionyl)

Figure 12: Cyclo(L-alanyl-L-histidyl)

Cyclic dipeptides will also be studied through solid-state NMR, in their solid,
crystalline form and as guests in the hydrophobic cavities of cyclodextrin inclusion
compounds.

Controlling the host-guest intermolecular potential can be achieved by

confining dipeptides in cyclodextrins of progressively larger cavity sizes.

Successful

inclusion of the cyclic dipeptide into a cyclodextrin will alter the ligand environment

17

thereby changing its dynamics, and thus changing the solid state NMR characterization of
the dipeptide. The cyclic dipeptide cyclo(L-leucyl-D-prolyl) was chosen for use in this
study because it has been previously characterized by X-ray crystallography and is
biologically active.

(3 cyclodextrin will be used to host the cyclo(L-leucyl-D-prolyl)

(Figure 13) in a 1:2 ratio o f guest:host. This study will also serve to complement related
studies of leucine and cyclo(L-leucyl-L-glycyl).

o

HN

o
Figure 13: Cyclo(L-leucyl-D-prolyl)

EXPERIMENTAL
Unless otherwise noted all of the reagents and solvents used were commercially
available. All syntheses were performed under argon, except for X-ray crystal growth,
and organic products and crystals were purged with argon for storage.

NMR was used

to check the purity o f all intermediates. The purity of ligands was confirmed using !H
NMR and

1T
C NMR spectroscopy. A Melt-Temp® melting point apparatus was used to

obtain all melting points. Nuclear Magnetic Resonance Spectroscopy was performed on
all samples using a Varian Mercury 400 MHz spectrometer and all chemical shifts are
reported relative to tetramethylsilane. Elemental Analysis was preformed by Atlantic
Microlabs, Inc. A. Deer and J. Poutsma performed all mass spectrometry experiments.

Synthesis of N-(Benzyloxycarbonyl)-L-Alanyl-L-Histidyl Methyl Ester (ZAHOMe)
Both the N-benzyloxycarbonyl protected dipeptide and the cyclic dipeptide were
prepared

by

modification

of

literature

procedures.20,21

A

solution

of N-

(benzyloxycarbonyl)-L-alanine (Z-AlaOH; 12.00 g, 8.95 mmol) in 50 mL of acetonitirile
was prepared with stirring under argon. Dicyclohexylcarbodiimide (DCC; 1.84 g, 8.95
mmol) and then 4-nitrophenol (1.25 g, 8.95 mmol) were added to the Z-AlaOH solution.
After stirring for approximately one hour, the precipitated DCU (dicyclohexylurea) was
removed by vacuum filtration. The filtrate was added to a solution of L-histidine methyl
ester (L-HisOMe; 2.17 g, 8.95 mmol) dissolved in acetonitrile (50 mL) and triethylamine
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(2.45 mL, 17.90 mmol) that had been stirring for 5.5 hours. This reaction mixture was
stirred under argon for 2 days.
Crude ZAHOMe was removed from solution via vacuum filtration and rinsed four
times with 10 mL portions of acetonitrile, until the solid was no longer yellow, and then
rinsed once with 20 mL of diethyl ether. The sample was sequentially suspended in 30
mL o f chloroform, 30 mL o f 0.5 M aqueous ammonia, and 30 mL of deionized water,
with vacuum filtration between washings.
ethanol/ether.

The white solid was recrystallized from

Crystals were isolated via vacuum filtration and then thoroughly dried

under vacuum overnight, yielding 1.08 g of white ZAHOMe crystals. MP:

NMR:

(DMSO-d6) (Appendix 1): 6 8.31 (d, J = 8.2 Hz, Hc), 7.53 (s, Hi), 7.49 (d, J = 9.3 Hz,
Hf), 7.36 (m, HaHa>,Ha”), 6.83 (s, Hj), 5.02 (dd, J = 12.9, 4.6 Hz, Hb), 4.47 (q, J = 7.2 Hz,
Hg), 4.08 (p, J = 7.3, 8 Hz, Hd), 3.57 (s, Hi), 2.38 (m, Hh), 1.20 (d, J = 8.5 Hz, He)

Synthesis of Cyclo(L-Alanyl-L-Histidyl) (cAH)
To remove the Z protecting group, ZAHOMe (1.08 g, 2.87 mmol) was
hydrogenated (40 psi, H 2 ) with 10% palladium-carbon catalyst (0.107 g) in 50 mL of
methanol for 6.5 hours. The methanol solution was vacuum filtered through a celite bed.
The filtrate was refluxed under argon for 60 hours and the solvent was removed by rotary
evaporation to produce a white solid. Cyclo-(L-alanyl-L-histidyl) was then recrystallized
from methanol and dried under vacuum overnight producing 0.4866 g (2.34 mmol) of
white cAH crystals (81% yield). MP: 244-247°C ’H NMR: (DMSO-d6) (Appendix 2):
S 8.19 (s, Hc), 8.10 (s, Hf), 7.98 (s, HO, 7.56 (s, Hb), 6.81 (s, Ha), 4.05 ( t,/ = 6.8 Hz , Hh),
3.81 (q, J = 6.9 Hz, He), 2.97 (dd, J= 3.4, 11.2 Hz, Hd), 2.86 (dd, J = 6.0, 8.6 Hz, Hd.),

20

0.97 (d, J =

6 .8

Hz, Hg) 13C NMR: (DMSO-d6) (Appendix 4):

6

169.04, 167.73, 135.38,

133.41, 118.06, 55.35, 50.49, 30.69, 19.64 Elemental Analysis:

Calculated for

(C9 Hi 2 N 4 0 2 )4 *CH3 0 H: C, 51.38; H, 6.06; N, 25.91; O, 16.65 Found: C, 51.35; H, 5.81

Synthesis of Cyclo-(L-Histidyl-L-Histidyl) (cHH)
Cyclo(L-histidyl-L-histidyl) was prepared with modification of the literature
procedure used by Abdehalden and associates . 2 2 L-Histidine methyl ester dihydrochloride
(5.00 g, 20.65 mmol) was dissolved in 100 mL of hot methanol and allowed to cool to
room temperature.

Sodium methoxide (4.99 mL of 30 wt % NaOCHs/CHsOH) was

added to the room temperature solution. One minute later, 50 mL of diethyl ether was
added. After approximately two minutes the NaCl that formed was removed via vacuum
filtration. The filtrate was reduced to dryness via rotary evaporation. The residue was
stirred in a 37°C oil bath for

8

days under argon. A white solid was removed from the

solution by means of vacuum filtration, and washed with several 20 mL portions of cold
methanol. Cyclo(L-histidyl-L-histidyl) was isolated by recrystallization from ultra pure
deionized hot water. The cHH was further dried overnight in a vacuum oven at 100°C,
yielding 355 mg of a white solid (12.5 % yield). MP: 269-278°C (dec) 'H NMR:
(DMSO-ds) (Appendix 3a):

8

7.98 (s, Hc), 7.58 (s, Hb), 6.78 (s, Ha), 3.98 (t, J = 4.1 Hz,

He), 2.99(dd, J = 4.0, 15.0 Hz, Hd.), 2.58 ( d d ,/= 8.9, 6.4 Hz, Hd) 13C NMR: (DMSOdf,) (Appendix 3b): 5 167.61, 135.53, 134.02,117.96, 55.22, 31.03
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Synthesis of N-(Benzyloxycarbonyl)-L-Alanyl-L-Methionyl M ethyl Ester
(ZAMOMe)
ZAMOMe and cAM were both prepared with modifcation to literature
procedure . 2 3

N-(Benzyloxycarbonyl)-L-alanine

(Z-AlaOH; 5.00 g, 22.39 mmol) was

dissolved in approximately 100 mL of still dried tetrahydrofuran and cooled to -10°C in
an ice/salt bath. N-methylmorpholine was added (2.46 mL, 22.39 mmol) to the cooled
solution. L-Methionine methyl ester hydrochloride (L-MetOMe; 4.47lg, 22.39 mmol)
was suspended in approximately 50 mL of N,N-dimethylformamide (DMF). The DMF
suspension was heated slightly to ensure saturation and cooled to room temperature.
Isobutyl chloroformate (2.904 mL, 22.39 mmol) was added to the Z-AlaOH solution
under a light stream of argon. In the next minute, triethylamine (3.06 mL, 22.39 mmol)
was

added

to

the

cooled

N,N-dimethylformamide

solution.

This

N,N-

dimethylformamide mixture was added to the tetrahydrofuran solution described above.
This solution was stirred under argon for three days. Salts were removed by vacuum
filtration, rinsing with tetrahydrofuran (THF) and the THF was removed via rotary
evaporation. Ultra pure water (20mL) was added and the solution was extracted with
methylene chloride (3 x 30 mL). The combined organics were dried with sodium sulfate
and the solution was reduced via rotary evaporation to a colorless oil. Ultra pure water
(100 mL) was added to the residue.

Following two days of refridgeration, white N-

(Benzyloxycarbonyl)-L-alanyl-L-methionyl methyl ester (ZAMOMe)

crystals were

removed via vacuum filtration and dried under vacuum overnight yielding 5.15 g (15.32
mmol) o f ZAMOMe (68.4% yield). 'H NMR: (DMSO-d6) (Appendix 4):

8

8.24 (d, J =

11.6 Hz, Hc), 7.41 (d, / = 7.7 Hz, Hf), 7.34 (m, Ha>Ha., Ha"), 4.99 (s, 2 Hb), 4.39 (q, J =

22

7.5, 8.9 Hz, Hg), 4.07 (p, J = 7.5,

6 .8

Hz, Hd), 3.62 (s, 3 Hk), 2.44 (m, Hi), 2.03 (s, 3 Hj),

1.99 (m ,H h), 1.20 (d, .7=7.7 Hz, He)

Synthesis of Cyclo(L-Alanyl-L-Methionyl) (cAM)
ZAMOMe (5.15 g, 15.32 mmol) was hydrogenated (40 psi, H 2 ) with 10%
palladium-carbon catalyst (0.0575 g) in 100 mL of methanol for 18 hours. This solution
was vacuum filtered through celite and the filtrate volume was reduced by rotary
evaporation to produce a thick yellow oil.

Crude L-alanyl-L-methionyl methyl ester

(AMOMe) oil was refluxed with -140 mL of toluene for 24 hours. Toluene was removed
through rotary evaporation, and the resulting translucent yellow cAM crystals were dried
under vacuum for ~18 hours, producing 3.46 g of crude cAM (78% crude yield).
Cyclo(L-alanyl-L-methionyl) was recrystallized in 350 mL of ethyl acetate.

The

resulting crystals were vacuum filtered and dried overnight under vacuum, yielding
6

.6 8 % cAM (0.2314 g). Attempts to retrieve more cAM from the mother liquor were

unsuccessful. Mp: 220-224°C 'H NMR: (DMSO-d6) (Appendix 5a):

8

8.15 (d, J =

8

Hz, 2 He), 3.93 (t, J = 5.1 Hz, Hd), 3.88 (q, J = 6.9 Hz, Hg), 2.58 (m, Hb), 2.01 (s, Ha),
1.94 (m, Hc), 1.24 (d, J = 6.9 Hz, Hf) 13C NMR: (DMSO-d6) (Appendix 5b):

8

169.65,

168.29, 53.80, 50.51, 32.78, 29.49, 19.81, 15.26 Elemental Analysis: Calculated for
C 8 H 1 4 N 2 O2 S: C, 47.52; H, 6.93; N, 13.86. Found: C, 47.79; H, 7.00; N, 13.66.
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Synthesis of N-(BenzyIoxycarbonyl)-D-Prolyl-L-LeucyI M ethyl E ster (ZPLOM e)
N-(Benzyloxycarbonyl)-D-proline (Z-ProOH; 2.00g, 8.02 mmol) was dissolved in
~20 mL o f still dried THF and then cooled to -10°C, while stirring under argon. Nmethylmorpholine (0.880mL, 8.02 mmol) was added to the reaction vessel. L-leucine
methyl ester hydrochloride (1.457g, 8.02 mmol) was dissolved in ~20 mL of N, Ndimethylformamide (DMF).

Isobutyl chloroformate (1.04 mL, 8.02 mmol) was then

added to the Z-ProOH solution. In the next minute, triethylamine (1.09 mL, 8.02 mmol)
was added to the DMF solution. The entire mixture was then added to the Z-ProOH
reaction vessel and allowed to react for 4 days under argon. The formed salts were
removed through vacuum filtration. The solvent was removed through rotary evaporation.
The residue was dissolved in ~40 mL of chloroform and extracted with ultra pure
deionized water (3 x 30 mL). The organic layer was dried with sodium sulfate, filtered
and rotary evaporated. Crystallization of the resulting clear, yellow oil was induced by
the addition o f -5 0 mL o f 4°C ultra pure water. The crystals were removed via vacuum
filtration and dried overnight in vacuo, resulting in 1.419 g (3.7 mmol, 46% yield) of
ZPLOMe. lH NMR: (DMSO-d6) (Appendix 6 ): 5 8.02 (s, Hg), 7.03 (m, Ha, H.*, Ha»),
4.19 (t, J = 7.5 Hz, Hf), 4.00 (t, J = 6.9 Hz, Hh), 3.63 (s, Hb), 2.31 (s, Hi), 2.11 (m, Hi, Hj),
1.83 (m, Hd), 1.35 (m, Hc), 0.87 (dd, J = 3.5, 3.0 Hz, Hk)

Synthesis of N-(Benzyloxycarbonyl)-L-Leucine (Z-LeuOH)
L-leucine (l.OOg, 7.62 mmol) was suspended in 20 mL o f ultra pure deionized
water. Two equivalents o f triethylamine (2.1 mL, 15.2 mmol) and 10 mL o f 95% ethanol
were added to the L-leucine suspension. Solid N-(benzyloxycarbonyloxy)-succinimide
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(1.89g, 7.62 mmol) was added to the reaction vessel. This mixture was allowed to stir
under argon for two days. The colorless solution was concentrated by rotary evaporation.
The residue was diluted with 50 mL of 100% ethanol and concentrated by rotary
evaporation three times. The residue was then dissolved in 10 mL of chloroform and
extracted three times with dilute HC1 pH=2.

The organics were dried with sodium

sulfate, filtered, and concentrated through rotary evaporation. The resulting Z-LeuOH oil
was dried in vacuo, yielding 1.612g (6.00 mmol, 78.7% yield). JH NMR: (DMSO-d6)
(Appendix 7):

6

12.57 (s, Hh), 7.59 (d, J = 9.2 Hz, Hc), 7.35 (m, Ha, Ha , Ha>), 5.03 (s, Hb),

3.96 (s, Hd), 1.47 (m, He), 1.45 (m, H f), 0.85 (dd, J = 6 .8 , 4.9 Hz, Hg)

Synthesis of N-(Benzyloxycarbonyl)-L-Leucyl-D-Prolyl Methyl Ester (ZLPOMe)
Z-LeuOH was dissolved in 75 mL o f still dried THF and chilled to -10°C, while
stirring under argon.

N-methylmorpholine (0.598 mL, 6.00 mmol) and isobutyl

chloroformate (0.778 mL, 6.00 mmol) were added to this mixture. Within one minute of
adding the isobutyl chloroformate to the reaction vessel, triethylamine (0.826 mL, 6.00
mmol) was added to D-proline methyl ester hydrochloride (D-ProOMe; 0.776g, 6.00
mmol) dissolved in 35 mL o f room temperature N,N-dimethylformamide (DMF). The
entire D-ProOMe/ DMF mixture was then added to the reaction vessel and allowed to
react, under positive argon pressure, for

1 0

days, at which point the resulting salts were

removed through vacuum filtration. An extraction with ultra pure deionized water of the
resulting Z-L-leucinyl-D-prolyl methyl ester (ZLPOMe) dissolved in -5 0 mL of
chloroform followed and was repeated twice.

Excess water was removed with the

addition of sodium sulfate and the chloroform was removed via rotary evaporation. The
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resulting yellow oil was dried overnight in vacuo yielding 1.9387g (5.15 mmol) of
ZLPOMe (85.8% yield). ‘H NMR: (DMSO-d6) (Appendix 8 ):

8

7.56 (s, Hc), 7.36 (m,

Ha,H a.,H a..), 5.03 (s, Hb), 4.36 (t, J = 12.8 Hz, H k), 4.25 (dd, J = 6.9, 8.5 Hz, Hd), 2.73 (s,
Hi), 2.18 (m, Hh, Hj, Hj), 1.90 (m, He, Hf), 1.53 (m, Hh, H„ Hj), 0.89 (m, Hg)

Synthesis of CycIo(L-Leucyl-D-ProIyl) (cLP)
The N-benzyloxycarbonyl protecting group was removed from the linear
dipeptides, ZLPOMe and ZPLOMe, via hydrogenation. ZLPOMe (1.9387 g, 5.15 mmol)
was added to 0.1931 g o f palladium over carbon (Pd/C) dissolved in ~50 mL of
methanol. The mixture was allowed to react with 40 psi of hydrogen gas for 48 hours.
Pd/C was removed from the mixture by vacuum filtration through celite. The resulting
filtrate was then reduced to a concentrated oil o f L-leucyl-D-prolyl methyl ester
(LPOMe) via rotary evaporation* and dissolved in 100 mL of toluene.

The LPOMe-

toluene mixture was allowed to reflux for ~24 hours under argon. Toluene was removed
through rotary evaporation and the remaining solid recrystallized in 50 mL of
tetrachloroethylene.

Off-white crystals were removed via vacuum filtration and dried

overnight. From ZLPOMe: 26.3% cLP (0.3311 g, 1.577 mmol). Mp: 163-165°C
NMR: (DMSO-d6) (Appendix 9a):

6

7.97 (s, He), 4.17 (t, J =

8

Hz, Hc), 3.98 (t, J =

Hd), 2.09 (m Hf), 1.80 (m Hj; h, 0, 1.34 (m Hb), 0.81 (q, J = 4 Hz, Ha).
(DMSO-d6) (Appendix 9b):

6

8

lH
Hz,

13C NMR:

170.99, 167.15, 59.21, 53.33, 45.63, 38.51, 28.21, 24.85,

23.62, 23.26, 22.68 MS: (H 2 0:C H 3 0H , 50:50 v/v) (Appendix 9c): 211, 194, 183, 181,
167, 155, 153, 138, 127,

8 6

, 70

* Crude hydrogenation products, LPOMe and PLOMe, were also used in mass spectrometric analysis by J.
Poutsma and A. Deer.
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From ZPLOMe: 28.7 % cLP (0.4078 g, 1.94 mmol) Mp: 158-164°C 'H NMR
(DMSO-d6) (Appendix 10a):

8

8.02 (s, He), 4.19 (t, J =

2.11 (m, Hf), 1.82 (m, Hg, h, i), 1.34 (m, Hb), 0.86
(Appendix 10b):

8

(q

8

Hz, Hc), 4.00 (t, J =

8

Hz, Hd),

J = 4 Hz, Ha) ,3C NMR: (DMSO-d6)

171.03, 167.13, 59.21, 53.35, 45.63, 38.55, 28.21, 24.86, 23.62,

23.27, 22.70 Elemental Analysis:

Calculated for CnHi8N 2 0 2: C, 62.86; H, 6.57; N,

13.33. Found: C, 62.40; H, 8.64; N, 13.20.

Attempted cLP Integration into p Cyclodextrin by Slow Evaporation (Method I)
p cyclodextrin (1.94 g, 1.710 mmol) was suspended in 40 mL of ultra pure water.
180 mg (0.856 mmol) o f cLP was added to the suspension and the mixture heated until
all materials dissolved. The solution was filtered by gravity, to remove impurities and 4
mL o f the resulting filtrate was transferred into each of four

8

mL vials. The vial caps

were attached loosely enough to allow for evaporation to occur. The remaining filtrate
was transferred into a 50 mL Erlenmeyer flask and covered with a Kimwipe.

The vials

and Erlenmeyer were allowed to sit, undisturbed for three weeks at which time clear
crystals were harvested and sent for elemental analysis. MP: 270-275°C Elemental
Analysis: Calculated for C 9 5 H 1 5 8 O7 2 N 2 : C, 46.00; H, 6.42; N, 1.13; O, 46.44. Found: C,
39.26; H, 6.75; N, 0.00 - consistent with pCD (C4 2 H 7 0 O3 5 - Calculated: C, 40.44 H, 6.23
O, 49.34).
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Attempted cLP Integration into p Cyclodextrin by Lyophilization (Method II)
P cyclodextrin (325 mg, 0.286 mmol) was suspended in 5 mL o f ultra pure water.
cLP (30 mg, 0.143 mmol) was added to the suspension and the mixture heated until the
solution became clear. The solution was gravity filtered into an 200 mL roundbottom
flask and frozen by rotating the roundbottom in a liquid nitrogen bath.

The frozen

mixture was then placed on a Labonco Freeze-Dry System/Freezone® 4.5 to dry
overnight, resulting in a white powder, 65% yield (230 mg, 0.0927 mmol). MP: 275285 °C Elemental Analysis: Calculated for C9 5 H 1 5 8 O7 2 N 2 : C, 46.00; H, 6.42; N, 1.13;
O, 46.44. Found: C, 42.84; H, 6.72; N, 1.07; O, 49.37.

Preparation of NMR solutions for NMR titrations of cMM and Hg(C 104)2
A 142 mM stock solution o f cMM (0.0746 g, 0.0832 mmol) in DMSO-d 6 was
prepared in a 2 mL volumetric.

Separately, a 20 mM stock solution o f mercury

perchlorate (9.07 mg, 0.02 mmol) was prepared in a 1 mL volumetric. Solutions with
metal-to-ligand ratios o f 0.0156, 0.0208, 0.0313, 0.0625, 0.125, 0.25, 0.50, 1.0, 1.25,
1.50, and 2.0 were prepared from the stock solutions and DMSO-d 6 . To prepare each
metal-to-ligand ratio, 65 pL aliquots of the 20 mM Hg(C 1 0 4 ) 2 -DMS 0 -d6 stock solution
were placed in NMR tubes and diluted with varying amounts of cMM and DMSO-d 6 to
obtain total volumes o f 650 pL, yielding 2mM o f Hg(II)in each tube.
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Preparation of NMR solutions for NMR titrations of cAM and Hg(CI04)2
A 142 mM stock solution of cAM (57.3 mg, 0.283 mmol) in DMSO-d 6 was
prepared in a 2 mL volumetric. A 20 mM solution of Hg(C 1 0 4 ) 2 (9.07 mg, 0.02 mmol) in
DMSO-dg was prepared in a 1 mL volumetric. Solutions with metal-to-ligand ratios of
0.156, 0.0208, 0.0313, 0.125, 0.25, 0.50, 1.00, 1.25, 1.50, 2.00 were prepared from the
stock solutions and DMSO-d 6 . To prepare each metal-to-ligand ratio, 65 pL aliquots of
the 20 mM Hg(C 1 0 4 ) 2 -DMS 0 -d6 stock solution were placed in NMR tubes and diluted
with varying amounts o f cAM and DMSO-d 6 to obtain total volumes of 650 pL, yielding
2mM o f Hg(II) in each tube.

Preparation of NMR solutions for NMR titrations of cAH and Hg(C 104)2
A 17.7 mM stock solution of cAH (7.65 mg, 0.0104 mmol) in DMSO-d 6 was
prepared in a 2 mL volumetric. Separately, a 20 mM stock solution was prepared with
Hg(C10 4 ) 2 (9.07 mg,

0 .0 2

mmol) in DMSO-d 6 in a

1

mL volumetric.

Solutions with

metal-to-ligand ratios o f 0.125, 0.25, 0.375. 0.50, 0.625, 0.75, 0.825, 1.0, 1.125, 1.25,
1.375 were prepared from the stock solutions and DMSO-d 6 . To prepare each metal-toligand ratio, 65 pL aliquots of the 20 mM Hg(C 1 0 4 )2 -DMS 0 -d 6 stock solution were
placed in NMR tubes and diluted with varying amounts o f cAH and DMSO-d 6 to obtain
total volumes o f 650 pL, yielding 2mM o f Hg(II)in each tube.

Preparation of NMR solutions for NMR titrations of cHH and Hg(ClC>4)2
A 17.7 mM stock solution of cHH (9.70 mg, 0.0104 mmol) in DMSO-d 6 was
prepared in a 2 mL volumetric. Separately, a 20 mM stock solution of Hg(C 1 0 4 ) 2 (9.07
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mg, 0.02 mmol) in DMSO-d 6 was prepared in a 1 mL volumetric. Solutions with metalto-ligand ratios o f 0.125, 0.25, 0.375, 0.50, 0.625, 0.75, 0.825, 1.0, 1.125, 1.25, 1.375
were prepared from the stock solutions and DMSO-d 6 . To prepare each metal-to-ligand
ratio, 65 pL aliquots of the 20 mM Hg(C 1 0 4 )2 -DMS 0 -d6 stock solution were placed in
NMR tubes and diluted with varying amounts of cHH and DMSO-d 6 to obtain total
volumes o f 650 pL, yielding 2mM of Hg(II) in each tube.

Preparation of NMR solutions for NMR titrations of cHH and Cd(C 104 ) 2»H2 0
A 17.7 stock solution o f cHH (9.70 mg, 0.0104 mmol) in DMSO-d 6 was prepared
in a 2 mL volumetric. A 20 mM stock solution of cadmium perchlorate hydrate (6.22
mg, 19.98 mmol) in DMSO-d^ was prepared in a 1 mL volumetric.

Solutions with

metal-to-ligand ratios o f 0.125, 0.25, 0.375, 0.50, 0.625, 0.75, 0.875, 1.0, 1.125, 1.25,
1.50 were prepared from the stock solutions and DMSO-d 6 . To prepare each metal-toligand ratio, 65 pL aliquots o f the 20 mM Cd(C 1 0 4 )2 «H2 0 -DMS 0 -d6 stock solution were
placed in NMR tubes and diluted with varying amounts of cHH and DMSO-d 6 to total
volumes o f 650 pL, yielding 2mM o f Cd(II) in each tube.

RESULTS AND DISCUSSION

I. ORGANIC SYNTHESES
Synthesis of Cyclo(L-Alanyl-L-Histidyl)
The synthesis of cAH was a multistep process.
synthesize

the

intermediate

First, it was necessary to

Z-L-alanine-p-nitrophenol

ester

by

adding

dicyclohexylcarbodiimide (DCC) and then 4-nitrophenol to a solution of Z-L-alanine
dissolved in acetonitrile.
peptide synthesis . 2 4

DCC is a carboxy group activating reagent used widely in

The DCC hydrates, forming dicylcohexylurea (DCU), which is

insoluble in acetonitriole. Since DCU cannot be readily separated from Z-L-alanyl-Lhistidyl methyl ester (ZAHOMe) by recrystallization, it was necessary to remove it by
vacuum filtration prior to combining with L-histidine methyl ester.
Triethylamine was added to L-histidine methyl ester dihydrochloride dissolved in
acetonitrile.

The triethylamine neutralized the dihydrochloride salt from L-histidine

methyl ester because o f the greater basicity of triethylamine over histidine. Removing
the dihydrochloride from L-histidine methyl ester permited coupling of L-histidine
methyl ester with Z-L-alanine-p-nitrophenol ester.

This coupling reaction produced

ZAHOMe, the result o f amide bond formation between the N terminus of histidine and
the C terminus o f Z-AlaOH. The reaction proceeded because the amide bond is more
stable than the existing ester bond between the C terminus of Z-AlaOH and the
nitrophenol group.
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The next step in cAH synthesis involved removing the N-(benzyloxycarbonyl) or
Z group from the N terminus of alanine. Hydrogenation of ZAHOMe with a palladium
on carbon catalyst in methanol removed the Z group, yielding AHOMe. AHOMe was
then refluxed in methanol for approximately 60 hours to facilitate the transesterification
reaction resulting in cAH.

Purification, achieved by recrystallization in methanol,

yielded 81% cAH (Figure 14).

CH-

NHHN.

N

+

ch

H

3c n

5 days

NO;

L-histidine methyl ester

Z*-L-alanine-p-nitrophenol

CHCHO
CH3
OCH-

H 2 (4 0 p si). P d /C
M eO H , 6 .5 h o u r s

NH

Z-L-alanine-L-histidine methyl ester

*Z = N-(Benzyloxycart>ony1oxy), an am ino protecting group.

cyc!o( L-a la ny l-L-h istidyl)

Figure 14: Synthesis of Cyclo(L-Alanyl-L-Histidyl)

Synthesis of Cylco(L-Histidyl-L-Histidyl)
Sodium methoxide was used to generate free amines from the commercially
available dihydrochloride salt of L-histidine methyl ester.

The cyclic dipeptide was

formed from the linear dipeptide produced through an initial intermolecular nucleophilic
attack o f an amine onto the carbonyl o f a methyl ester and elimination o f methanol.
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Unimolecular cyclization of the dipeptide methyl ester through intramolecular
nucleophilic attack produced the cyclic dipeptide. Recrystallization from water produced
cHH in 12.5% yield (Figure 15).

2 N aO C H 3

2 HCI

2

HN

37°C , 8 d ay s

NH

H
H
L-histidine methyl ester dihydrochloride

cyclo-(L-histidyl-L-histidyl)

Figure 15: Synthesis of Cyclo(L-Histidyl-L-Histidyl)

The cyclic dipeptide is the major product of this reaction, despite the existence of
several simultaneous and competing reactions. First, the six-membered ring structure of
cHH is more stable than any smaller or larger ring structures that could form. Also of
importance is the close proximity of the carbonyl and amine in the dipeptide, which
favors

internal

attack

over

intermolecular

attack.

Further,

this

reaction

is

thermodynamically favored by the greater stability of amides over esters.

Synthesis of Cyclo(L-Alanyl-L-Methionyl)
The synthesis o f cAM requires the preparation of several intermediates.
ZAMOMe, the first of these intermediates, was synthesized via a multistep addition
reaction. First, triethylamine was added to a solution containing DMF and L-methionine
methyl ester dihydrochloride to neutralize the dihydrochloride salt. In a separate vessel,
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N-methylmorpholine and isobutyl chloroformate were added to Z-AlaOH to facilitate the
addition of Z-AlaOH to L-methionine. In this reaction, N-methylmorpholine was added
to facilitate coupling between Z-AlaOH and isobutyl chloroformate by neutralizing the
hydrochloric acid formed. The two solutions were then combined within one minute of
having added isobutyl chloroformate to the Z-AlaOH solution, producing ZAMOMe.
This coupling reaction was driven by the formation of an amide bond, which is more
stable than the existing Z-L-alanyl-isobutyl formate ester bond.

N -m e th y lm o rp h o lin e . Iso b u ty l C h lo ro fo rm a te

.0

H

T H F/D M F

0

L -m e th io n in e m eth y l e s t e r h y d ro c h lo rid e

Z -L -ala n in e

-0
3

H2 (4 0 p si), P d /C

R e flu x in T oluene^

M eO H , 2 4 h rs.

2 4 h rs.

*

O
Z -L -a la n in e -L -m e th io n in e m eth y l e s te r

s

'Z = N-(Benzyloxycarbonyloxy), an am ino protecting group.

cy clo (L -alan y l-L -m eth ionyl)

Figure 16: Synthesis o f Cyclo(L-Alanyl-L-Methionyl)

The next intermediate in the synthesis of cyclo(L-alanyl-L-methionyl) was
AMOMe. Hydrogenation of ZAMOMe over a Pd/C catalyst was used to remove the N-
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(benzyloxycarbonyl) group (Z), which was protecting the N terminus of the dipeptide.
This reaction was favored, as a carbamate bond is subject to reduction much more readily
than an amide bond. After 24 hours of hydrogenation in a methanol solution, AMOMe
was produced. To facilitate transesterification, the AMOMe was refluxed in toluene for
24 hours. Recrystallization from ethyl acetate yielded 7% cAM (Figure 16). Attempts
to obtain more product from the filtrate were unsuccessful.

Synthesis of Cyclo(L-Leucyl-D-Prolyl)
The synthesis o f cLP is very similar to that of cAM.

The major difference

between the two syntheses is the need to couple N(benzyloxycarbonyloxy) succinimide
to L-leucine in the synthesis of cLP, whereas commercially available Z-L-AlaOH was
used in the synthesis o f cAM. The reason for this additional step is the future interest in
synthesizing cLP using labeled leucine.
Once Z-LeuOH had been adequately dried, the coupling reaction between Z-Lleucine and isobutyl chloroformate was prepared. N-methylmorpholine was added as a
base to facilitate coupling between Z-L-leucine and isobutyl chloroformate, to form Z-Lleucine isobutyl formate.

Z-L-leucine isobutyl formate was then combined with L-

proline methyl ester that was treated with triethylamine to remove the hydrochloride
group from the amino acid. The resulting major product was ZLPOMe.
ZLPOMe was then hydrogenated with a palladium over carbon catalyst in
methanol to remove N-(benzyloxycarbonyl),

the N terminus protecting group.

Hydrogenation for 48 hours yielded LPOMe, which was refluxed in toluene. After 24
hours o f refluxing, the toluene solution was reduced via rotary evaporation and the
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resulting solid was recrystallized from tetrachloroethylene, yielding 26% cLP (Figure
17).
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Figure 17: Synthesis of Cyclo(L-Leucyl-D-Prolyl).
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II. MASS SPECTROM ETRY ANALYSIS OF CYCLO(L-LEUCYL-D-PROLYL)

J. Poutsma and A. Deer conducted all mass spectrometry experiments using a
quadrupole ion trap instrument (Finnigan LCQ-Deca™) fitted with an external
electrospray ionization source. Dilute solutions (ca. 5 x 10' 3 and 5 x 10' 4 M) of the
cyclic/linear dipeptide in slightly acidified (1% acetic acid) H 2 0:C H 3OH (50:50 v/v)
were directly infused into the mass spectrometer at flow rates in the range of 5-50
pL/min. A typical mass spectrum of cLP is shown in Appendix 9c. Ions with the massto-charge ratio o f the singly protonated dipeptide were isolated with a typical isolation
width o f 4-5 amu.

The mass-selected ions were subjected to collision-induced

dissociation with the background helium buffer gas serving as the target.

Typical

activation energies were in the range of 10-15 V (peak-to-peak, lab frame) and the
activation time was 30ps. Product ion scans were then collected using the resonance
ejection method. The process o f ion isolation / fragmentation was repeated to give MS ,
MS4, and MS 5 spectra.
Cyclo(L-leucyl-D-prolyl) was isolated and fragmented.

The information

presented in Figure 17 depicts the suspected fragmentation pattern of the cyclic dipeptide.
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III.

CYCLO(L-LEUCYL-D-PROLYL) INTEGRATION INTO P

CYCLODEXTRIN

Integration of cyclo(L-leucyl-D-prolyl) into p cyclodextrin (PCD) was attempted
by two methods, both based on the procedure outlined by Brett and associates . 2 5 In one
method (Method I), the cLP and PCD were combined and X-ray quality crystals were
obtained by slow evaporation of the 1:2 cLP:pCD solution. However, elemental analysis
of the crystals indicated isolation of pure pCD.
Prior to harvesting the crystals grown in Method I, there was concern pCD water
inclusion in the crystalline structure of the complex would present a problem, thus
Method II was proposed. In this method, the same procedure was used to combine cLP
and PCD, the solution of which was then lyophilized. Using the lyophilization method
we were able to prepare a powder with reasonable nitrogen content, suggesting the
presence o f cLP. However, the elemental analysis of this sample was not consistent with
a hydrate of 1:2 cLP'.pCD.

These results combined with the elemental analysis

characterization o f the crystals produced in Method I, suggest that cLP is not intercalating
inside the PCD as desired. This may indicate that the cavity was either too large or too
small. The cLP may also be interacting with the exterior as opposed to the interior of the
pCD cavity. Future attempts at cLP integration into a cyclodextrin are warranted, but
should be attempted with a and y cyclodextrin.

These cyclodextrins are larger and

smaller than pCD, and integration into either one would be adequate for solid-state NMR
studies.
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IV. NMR SOLUTION-STATE STUDIES OF HG(II) COORDINATION

Solution-State Investigations of Cyclo(L-Methionyl-L-Methionyl)
A series of solutions in which the Hg:cMM ratio was increased from 0 (free
ligand) to 2:1 with 2 mM Hg(II) were prepared in DMSO-d 6 .
performed on these solutions at room temperature.

Proton NMR was

Figure 19 depicts the free ligand

cMM with proton assignments. Figure 20 shows a plot of chemical shift vs. metal-toligand ratio of hydrogen atoms He, Hd, Hb, Ha, and Hg. Figure 21 shows a stacked plot of
proton NMR spectra at selected metal-to-ligand ratios.
H3aC-—s

s

~~CH3a

Figure 19: cMM

The metal-to-ligand ratios 0.0156, 0.0208, 0.0313, 0.0625, 0.125, 0.25, 0.5, 1.0,
1.25, and 1.50 were selected for to investigate the formation of 1:1 and 1:2 Hg(II):cMM
complexes. At the [Hg]/[cMM] ratio 0.0313, two small peaks (Hb’ and Hb”)are observed
at 3.39 ppm and 2.47 ppm. These peaks increase in intensity, but remain at the same
chemical shift over the course of the study. This suspicious behavior may be explained
as the two Hb protons becoming prochiral in the presence of Hg(II) and appearing at
different resonances. This was difficult to assess secondary to the presence of broad
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Figure 20: Chemical shifts o f protons He, Hd, Hb, Hb’, Hb ”, Ha, Ha’, and Hg in cMM in
the presence o f Hg(C 104)2 as a function of metal-to-ligand ratio in DMSO-d6 at room
temperature. Total metal concentration was 2 mM.
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Figure 21: Stack plot of several *H NMR spectra of cMM in the presence of Hg(C 104)2
at room temperature in DMSO-cU. Total metal concentration was 2 mM. Metal-to-ligand
ratios = a) 0.0156, b) 0.25, c) 0.50, d) 1.0, e) 1.25.
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water and DMS0-d6 peaks in the same region of the spectrum. A third peak (Ha’) also
appeared at the 0.0313 ratio. This peak, a singlet, appeared at 1.05 ppm and remained at
that resonance throughout the rest of the study. It is possible that this peak is the methyl
peak o f a Hg:cHH complex.

The noticeable broadening o f Ha beginning at the 0.25

Hg:cMM ratio and then the sudden sharpening o f the peak at the 1.0 ratio of Hg:cMM,
was also o f interest.

This broadening might be an indication of possible exchange

occurring between the Ha proton of free ligand and the Ha proton of a mercury complex,
possibly a 1:2 complex since the change occurs suddenly at the 1.0 ratio. The sharpening
of Ha may be secondary to the decrease in available free ligand for exchange at the 1.0
ratio.
These interpretations are speculative, especially since no JH change in chemical
shift o f the protons Hc, Hd, and He was observed.

Since the methionyl side chain is

commonly involved in binding divalent metal ions in vivo, one would expect to observe
either a change in the chemical shift of the methionyl protons (especially Ha and Hb) or
observe the appearance o f new peaks, representative of some Hg(II):cMM complex. The
appearance o f new peaks Hb’, Hb”, and Ha>, may be suggestive of this Hg(II):cMM
complex forming. However, while cMM is reported to complex in a 1:2 ratio with Ag(I),
in vitro, our observations neither support nor refute this . 2 6 Thus the limited availability of
previous NMR studies and the speculative nature of our observations warrant further
NMR evaluation o f cMM and Hg(II).
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Solution-State Investigations of Cyclo(L-Alanyl-L-Methionyl)
Since the changes observed in the Hg:cMM titration study did not
definitively suggest the presence of a Hg(II):cMM complex, a repeat titration study that
substituted cAM for cMM was proposed. The cyclic dipeptide cAM was chosen because
it has an alanine side chain in place of one of the methionine side chains of cMM, and
alanine is incapable of metal binding. Thus, it was expected that the methionyl protons
would exhibit the same changes as observed in the previously discussed Hg:cHH titration
study, while the alanyl protons would not exhibit any changes over the course of the
study.
A series of solutions in which the Hg:cAM ratio was increased from 0 (free
ligand) to 2:1 with 2 mM mercury perchlorate were prepared in DMSO-d 6 . Proton NMR
was performed on these solutions at room temperature.

Figure 22 shows a plot of

chemical shift vs. metal-to-ligand ratio of selected hydrogen atoms. Figure 23 shows a
stacked plot of proton NMR spectra at selected metal-to-ligand ratios. Figure 24 shows
cAM with proton assignments.
O

H2c
O
Figure 24: cAM
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Figure 23: Stack plot o f several 'H NMR spectra of cAM in the presence o f Hg(ClC>4)2
at room temperature in DMSO-d6. Total metal concentration was 2 mM. Metal-to-ligand
ratios = a) 0.0156, b) 0.25, c) 0.50, d) 1.0, e) 1.25.
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The methionyl side chain is commonly involved in binding divalent metal ions in
vivo and it was expected that the greatest effects of mercury(II) on cAM would be
demonstrated by a change to the resonances for Ha, Hb, Hc, Hd, and He. As observed in
the Hg(II):cMM titration study, two peaks appear at the Hg(II):cAM ratio of 0.0313 at
3.40 ppm and 2.45 ppm. This behavior suggests that the methylene protons (Hb) become
prochiral in the presence o f Hg(II) because the formation o f a Hg(II):cAM complex
changes the effective environment. These peaks increase in intensity but remain at the
same chemical shift over the course of the study. Also of interest is the appearance o f a
new singlet (Ha>) at 1.05 ppm at the 0.0313 Hg(II):cAM ratio. This peak increases in
intensity throughout the remainder of the study, while Ha is noticed to decrease in
intensity throughout the remainder of the study. This intensity change between Ha and
Ha- suggests the formation of an Hg(II):cAM complex. The broadening of the amide
peaks at 8.155 ppm (Hh) and 8.182 ppm (He) is also interesting, as it suggests the
occurrence o f exchange, a process that occurs on a time scale comparable to the NMR
time scale or the frequency difference between nuclear environments.

Finally, Ha

broadened at the ratios 0.25 and 0.5, and then sharpened at ratios above 0.5, only to
broaden again above 1.0. The change in broadening at the 0.5 ratio of Hg(II):cAM may
suggest the formation o f a 1:2 Hg(II):cAM complex, while the change above 1.0 may be
suggestive o f 1:1 complex formation. These interpretations are merely speculative, as
concrete evidence for such interactions has not been observed.
The resonances for the alanyl protons, Hf and Hg were nearly unchanged
throughout the series. The results of this study support the findings of the previously
discussed Hg(II):cMM titration study in that Hg(II) is suggested to interact with the
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sulfur of methionine. However the exact interaction and complex formation will not be
fully understood and known without further NMR studies and X-ray analysis.

Solution-State Investigations of Cyclo(L-Hisitdyl-L-Histidyl)

A series of solutions in which the HgicHH ratio was increased from 0 (free
ligand) to 1.375:1 with 2 mM mercury perchlorate was prepared in DMSO-d 6 .

Proton

NMR was preformed on these solutions both at room temperature and at 20°C. Figure 25
shows a plot of chemical shift vs. metal-to-ligand ratio o f selected hydrogen atoms in the
imidazole region. Figure 26 shows a stacked plot of proton NMR spectra at selected
metal-to-ligand ratios. Table 1 and 2 show proton chemical shifts of the initial and repeat
metal-to-ligand titration studies of Hg:cHH.
The histidine side chain is a common binding group for divalent metal cations in
vivo. cHH (Figure 27) has been shown to form 1:1 and 1:2 metal complexes with Ag (I)
77 78

and Cu (II). ’

Other studies have shown that the 5 nitrogen o f the imidazole ring were

bound to Cu(II) in the solid state.
but were unsuccessful.

70

Attempts were made to complex cHH with Hg (II),

Although X-ray quality crystals were not obtained, observed

NMR data suggests that the

8

nitrogens in the imidazole rings of cHH are primarily

responsible for metal coordination.
O
;C H b

HN
NH,

0
Figure 27: cHH
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Figure 25: Chemical shifts of protons Hf, Hb, Ha, He, Hd’, and Hd in cHH in the presence
of Hg(C104)2 as a function of metal-to-ligand ratio in DMSO-d6 at 20°C are shown.
Total metal concentration was 2 mM.
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The metal-to-ligand ratios of 0.125, 0.25, 0.375, 0.50, 0.625, 0.75, 0.875, 1.0,
1.125, 1.250, and 1.375 were selected to investigate formation of 1:1 and 1:2 complexes.
Free cHH was observed to have three relatively sharp peaks between 8.0 and 6.7 ppm.
Two of these peaks (Ha and Hb) correspond to the C-H hydrogens on the imidazole ring.
The other is the amide proton (H f) found on the nitrogen next to Ca in the cHH ring.
This proton shifted the most downfield, moving 1.004 ppm over the course of the study,
suggesting the occurrence o f changes in the ring structure, like folding.
Each o f the C-H imidazole proton resonances (Hb, Ha) were observed to shift
significantly downfield (0.746 and 0.572 ppm respective total chemical shifts) over the
course o f the study.

These peaks also broadened significantly compared to those

observed in the ]H NMR o f free ligand.

This is suggestive of an exchange process

occurring on a time scale comparable to the NMR time scale or the frequency difference
between nuclear environments.

Hc was not observed at all in this study.

This was

expected since proton NMRs of cHH spiked with D 2 O and MeOD show this proton is
highly exchangeable with both solvents. All of these observations suggest the primary
Hg(II) and cHH interaction occurs with the

6

nitrogen, as the proton Hb experiences the

most signifcant downfield shift (0.746 ppm) o f the two C-H imidazole protons as the
Hg:cHH ratio is increased. Also indicative of Hg(II) interaction with the imidazole ring
is the shift observed in proton Hd. This proton shifts closer to Hd* from the ratio 0.25 to
1.0 and then appears to move upfield above the 1.0 Hg(II):cHH ratio. This would suggest
two things, the first being Hg(II) interaction with the imidazole ring that changes the
environment o f the Hd and Hd> (methylene) protons by stopping Ca—Cp bond rotation.
Also, since the upfield shift in Hd’ resonance stops at the. 1.0 ratio, the formation of a 1:1
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Hg(II):cHH complex is suggested. The formation of a 1:2 Hg(II):cHH complex may be
suggested by the change in the slope of the Hd proton chemical shift plotted in Figure 25.
X-ray analysis and further studies will elucidate the exact complex formed.
Overall, this data was highly reproducible. In only one case (proton H f at 0.375
[Hg]/[cHH]) was the data difference greater than 0.094 ppm. The change observed in
chemical shifts o f the methylene protons of cHH was similar to the change observed in
the chemical shift o f the methylene protons of cMM. This similarity between the two
studies may further support Hg(II) interaction with the sulfur on the methionyl side chain.

Solution-State Investigations of Cyclo(L-Alanyl-L-Histidyl)
Since alanine is a non-metal binding side chain, cAH was studied with the hopes
that titration studies o f the dipeptide with Hg(II) would provide better insight into
understanding the Hg(II)-histidine interactions observed in the Hg(II):cHH study.

A

series o f solutions in which the Hg:cAH ratio was increased from 0 (free ligand) to 1.375
with 2 mM mercury perchlorate was prepared in DMSO-d 6 . Proton NMR was preformed
on these solutions at 20°C. Figure 28 shows a plot of chemical shift vs. metal-to-ligand
ratio o f selected hydrogen atoms. Figure 29 shows a stacked plot of proton NMR spectra
at selected metal-to-ligand ratios.
Free cAH (Figure 30) was observed to have four sharp peaks (H f, H j, Hb, and Ha)
between

6 .8

and 8.2 ppm. Each of these peaks were observed to broaden in the presence

o f Hg(II). This broadening is suggestive of the occurrence of an exchange process. Also
o f interest was the upfield shift of the amide proton H f and the C-H imidazole protons Hb
and Ha by 0.904, 0.546, and 0.586 ppm, respectively, between free ligand and the 1.375
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Hg(II):cAH ratio.

A change in the Hb and Ha proton environments suggested by the

change in the chemical shift of these protons may also indicate the formation of a Hg(II)cAH complex. Hb shifts the greatest over the course o f the study, which supports the
interaction o f mercury (II) with the 5 nitrogen on the imidazole ring. Since Hb is the
closest proton of the imidazole ring to the proposed mercury interaction site, one would
expect to note the greatest change the chemical shift of this proton. Another point of
interest is the upfield shift o f Hf, which suggests a change in the cAH ring environment
consistent with the formation of a Hg(II)-cAH complex. The change in the slope of the
protons Hf, Ha, and Hb (plotted in Figure 27) seems to level off at ratios of Hg(II):cAH
above 0.5. This may suggest the possible formation of a 1:2 Hg(II):cAH complex. Also,
the change observed in Hd between 0.25 and 0.5 from a singlet to an overlapping doublet
of doublets indicates a change in the stereochemistry of the methylene protons, which
may support this possibility of 1:2 complex formation. The

doublet of doublets reverts

to a singlet at ratios above 0.625, which is why only two Hd’ points (represented by an x)
are plotted in Figure 28. Hd also broadens in the presence o f Hg(II), suggesting the
occurrence of an exchange process, which further suggests the formation of a Hg(II):cAH
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complex. This interpretation o f results is only cursory, requiring further NMR and X-ray
analysis studies for confirmation.
The alanyl protons Hg, Hh, and Hi remained nearly unchanged throughout the
study, shifting at total o f 0.166 ppm, 0.094 ppm, and 0.311 ppm, respectively, over the
course o f the study. This indicates that the environment of the alanyl protons changes
minimally over the course of the study. Therefore, the association between mercury (II)
and cAH most likely occurs on the histidyl side chain since the greatest change in
chemical shift is observed with the histidyl protons, which supports the observations and
analysis o f the Hg(II):cHH titration study.
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IV. NMR SOLUTION-STATE STUDIES OF CADMIUM(II) COORDINATION

Solution-State Investigations of Cyclo(L-Histidyl-L-Histidyl)
A series o f solutions in which the Cd:cHH ratio was increased from 0 (free
ligand) to 3:2 with 2 mM cadmium perchlorate was prepared in DMSO-d 6 . Proton NMR
was performed on these solutions at room temperataure.

Figure 31 shows a plot of

chemical shift vs. metal-to-ligand ratio of selected hydrogen atoms. Figure 32 shows a
stacked plot o f proton NMR spectra at selected metal-to-ligand ratios.
In general, peak broadening, suggestive of exchange processes occurring, is
apparent in all cadmium containing samples, when compared to the ]H NMR spectra of
free cHH (Appendix 5). The presence of free ligand is apparent throughout the study, as
indicated by constant slope o f the solid shapes in Figure 31. The intensity of the free
ligand peaks noticeably decreases over the course of the study, suggesting a decrease in
overall free ligand. Additional peaks at 8.19, 7.43, 6.04, and 4.31 ppm arise at the 0.375
and 0.50 ratios o f Cd’.cHH and increase in intensity over the course of the study
suggesting that a Cd:cHH complex is forming. Since two sets of cHH resonances were
not observed in identical HgicHH studies, cadmium may exchange more slowly than
mercury under these study conditions. Analysis o f the behavior o f the Hd and Hd’ protons
was complicated by potential overlap with the broad water and DMSO-d 6 resonances.
However, it appears the peaks o f Hd and Hd- migrate to overlap at 2.83 ppm. The overlap
of the two protons begins at the 1.0 ratio of Cd(II):cHH and continues throughout the rest
of the study. This trend suggests the formation of a 1:2 Cd(II):cHH complex.
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[Cd]/[cHH] Titration Study
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Figure 31: Chemical shifts o f protons Hf, Hb, Ha, He, and Hd in cHH in the presence of
Cd(C 104 )2*H2 0 as a function o f metal-to-ligand ratio in DMSO-d6 at room temperature.
Total metal concentration was 2 mM.
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Figure 32: Stack plot of several *H NMR spectra of cHH in the presence of
Cd(C 104 )2-H2 0 at 20°C in DMS0-d6. Total metal concentration was 2 mM. Metal-toligand ratios = a) 0.25, b) 0.50, c) 0.75, and d) 1.0
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Recent studies have shown that both cadmium (II) and mercury (II) can be
substituted for and readily adopt the coordination environment of native metal ions . 1 0 , 3 0 ' 3 4
Comparable binding o f Cd(II) and Hg(II) to small ligands has also been observed . 3 5 ]H
NMR studies with small, non-oxygen containing ligands have suggested that the solution
equilibria o f the Cd(II) and Hg(II) systems were comparable as the proton chemical shifts
with various mole ratios o f Cd(II) were only shifted slightly downfield in comparison to
identical ratios o f Hg(II) . 3 5

In the Cd:cHH titration study, the ligand-metal complex

proton shifts are significantly different from the trend observed in the Hg:cHH study.
In general, cHH proton chemical shifts increase in the presence o f Hg(II), whereas
in the cadmium study no general trend o f proton shifting can be assessed. The Cd(II)
complex related protons He’ and Hf shift slightly downfield from free ligand (0.3 and 0.2
ppm, respectively), while Hb> shifted slightly upfield (0.2 ppm) and Ha> shifted
significantly upfield (0.8 ppm). This appreciable difference in trends between cadmium
and mercury titration studies may be attributable to the presence of oxygen in the cHH
ligand used. This is supported by previous indications that cadmium (II) and mercury
(II), while in the same periodic
preferences.
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family, possess

complementary coordination

•

Cadmium preferentially binds to hard ligands like oxygen, while softer

ligands, like sulfur, are preferred by mercury . 3 5 Since cadmium is more oxophilic, there
is a possibility o f different binding modes with oxygen containing ligands, which may
explain the difference between the observed Hg(II) and Cd(II) complexing trends with
cHH.

CONCLUSION

The syntheses o f cyclo-(L-alanyl-L-methionyl) was completed by using a strategy
that employed protecting the nitrogen terminus with N-benzyloxycarbonyloxy and
protecting the carboxy terminus with a methyl ester to prevent multimerization and
racemerization.

The syntheses of cyclo-(L-alanyl-L-histidyl) and cyclo(L-leucyl-L-

prolyl) were completed using

similar strategies.

Integration of cLP into pCD was

unsuccessful because cLP did not associated with pCD as predicted. This may be a result
of the PCD cavity being either too small or too large. Future studies should be aimed at
attempting cLP integration into either a or yCD, which have different cavity sizes.
The analysis o f cMM NMR titration data in DMSO-d 6 proved to be more difficult
than expected. The coordination of Hg(II) and methionyl is remotely suggested by both
the cMM and cAM titration studies, which also indicate the possibility of 1:2 and 1:1
complex formation.

However, further evaluation o f these interactions is needed to

substantiate these rudimentary conclusions.
The histidyl side chain, specifically the 5 nitrogen of the imidazole ring, was
tentatively established as the primary site for Hg(II) interaction in cAH and cHH.
Analysis indicates that there is an intermediate exchange rate in the equilibrium that is
too slow on the NMR time scale for a sharp, time averaged signal. In the presence of
mercury, there is evidence that the exchange rate is too fast for individual species
detection.

Analysis o f the Cd(II) titration study provides some evidence that the
60
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exchange process in the presence of cadmium is slower than that observed in the mercury
study, as multiple species peaks are distinct.

These conclusions are however merely

speculative, as X-ray analysis of solid crystals corresponding to these complexes has not
been achieved.
The low solubility of cHH and its complexes in solution has proven the greatest
problem in growing the crystals needed for X-ray analysis. While solvents have been
discovered to solvate Hg(II):cHH complexes, they possess high boiling points and are not
favorable for slow evaporation crystal growing.

Alternate strategies, like cosolvent

layering, have not been successful at this time, as a cosolvent that is miscible with DMSO
in all proportions that does not solvate cHH or its complexes has not been identified.
Immediate future plans include synthesis and X-ray analysis of Hg:cHH crystals
obtained in 1:1 and 1:2metal-to-ligand ratios, as well as X-ray analysis of a or y
cyclodextrin integrated cLP crystals made in 1:2 ratio of guest to host. Pending are solidstate NMR analyses o f labeled and unlabeled cLP as a free ligand and as a guest in either
a or y cyclodextrin in 1:2 guest to host ratio. Also incomplete at this time are mass
spectrometry studies on cLP, LPOMe, PLOMe and PPOMe.

Overall, this study was

designed to provide a library o f characterizations of the synthesized dipeptides to be
compared with results o f the eventual investigation of the potential of 199Hg NMR to
structurally characterize metalloproteins. Future research in this laboratory is aimed at
exploring the utility o f mercury NMR in the characterization of structural features of
protein metal coordination sites.
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A ppendix 5: (a)
NMR of 118 mM cAM in DMSO-d6 at 100°C. (b) 13C NMR of 118
mM cAM in DMS0-d6 at 20°C.

67

H2kC

\

CH
CH

CH

OCH

CH

HX

CH
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A ppendix 7: !H NMR of Z-LeuOH in DMSO-d 6 at 20°C. Concentration of sample
unknown secondary to Z-LeuOH being an oil.

69

CH3g
CH
CH

CH

CH

A ppendix 8 :
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unknown secondary to ZLPOMe being an oil.

Appendix 9: (a) ‘H NMR o f 140 mM cLP in DMSO-d6 at 20°C. (b) 13C NMR of 140
mM cLP in DMSO-d6 at 20°C.
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